PCSK9 inhibitor
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for PCSK9 inhibitor, covering 2015-09-29 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung [Phase 2]